Mercury Laboratories share news, announcements and annual reports
BSE: 538964Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹734.00.
30 Oct: open ₹790.00, high ₹790.00, low ₹790.00
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹95 Cr2,954th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.44%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1
Mercury Laboratories share news and announcements
423 announcements, routine notices left out, newest first. Page 6 of 9.
May 2020
30 May · Corporate action
20 May · Board meeting
Meeting on 30 May 2020: final dividend, audited results, annual general meeting and quarterly results14 May · Legal
Exchange has sought clarification from Mercury Laboratories Ltd on May 14, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....6 May · Mercury Laboratories Limited-Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Apr 2020
22 Apr · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2020
29 Feb · Management
Jan 2020
28 Jan · Board meeting
Meeting on 5 Feb 2020: quarterly results21 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Jan · Rating
Dec 2019
9 Dec · Mercury Laboratories Limited Disclosure Under Regulation 23(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015 - Related Party Transactions For The Half Year Ended September 30, 2019
4 Dec · Disclosure On Related Party Transactions Under Regulation 23(9) Of SEBI LODR Regulations, 2015
Nov 2019
5 Nov · Board meeting
Meeting on 13 Nov 2019: quarterly results
Oct 2019
17 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....16 Oct · Mercury Laboratories Limited - Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Period Ended On September 30, 2019
14 Oct · Mercury Laboratories Limited-Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....4 Sep · Reg. 34 (1) Annual Report
Aug 2019
Jul 2019
26 Jul · Management
22 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results13 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....5 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
26 Jun · Disclosure On Related Party Transactions Under Regulation 23(9) Of SEBI LODR Regulations, 2015
May 2019
31 May · Corporate action
31 May · Corporate action